Key Details of Re-appointment
- Term: Three years commencing from February 12, 2027, to February 11, 2030 (both days inclusive)
- Current Status: Subject to approval of the shareholders of the Company
- Retirement Provision: Dr. Joshipura shall be liable to retire by rotation
- Terms and Conditions: As recommended by the Nomination and Remuneration Committee
Executive Profile
Dr. Hardik Joshipura currently serves as the Managing Director & CEO of the company. Prior to joining Innovassynth, he held various senior leadership positions at Sigma-Aldrich and later at Merck KGaA, with extensive experience in manufacturing, sales, and global strategic marketing. He began his career at Zydus Cadila, where he led Contract Research R&D for the Fine Chemicals business. Dr. Joshipura holds a Ph.D. in Organic Chemistry and is an alumnus of Harvard Business School (HBS), Boston, USA, where he completed an Executive MBA.
Governance Disclosures
- Relationships: Dr. Hardik Joshipura is not related to any Directors or Key Managerial Personnel of the Company
- Directorship Status: Not applicable for this disclosure type
- Regulatory Standing: Dr. Hardik Joshipura is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority
Compliance Information
The disclosure is made pursuant to Regulation 30 of the Listing Regulations read with Annexure 18 of Chapter V, Section V-A of the SEBI Master Circular dated January 30, 2026. The document is signed by Sameer Salim Pakhali, Company Secretary & Compliance Officer (ACS 55746).